Ideaya Biosciences

Yujiro S. Hata, Founder and CEO
Yujiro S. Hata, Founder and CEO
USA | Funding: $694.1M (+)

Website: https://www.ideayabio.com/

IDEAYA is an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality medicines for genetically defined patient populations and immuno-oncology therapies targeting immuno-metabolism and innate immunity.